MANNKIND CORP

MNKD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Revenue $27.9M $11.7M $174.8M $0 $0 $0 $35.0K $50.0K
Cost of Revenue $19.4M $17.2M $17.1M $64.7M
Gross Profit $8.5M $-5.5M $157.6M $-64.7M
Gross Margin 30.4% -46.7% 90.2%
Operating Expenses
Research & Development
SG&A Expense $79.7M $75.0M $46.9M $41.0M $79.4M $59.7M $45.5M $40.6M
Operating Income $-76.6M $-108.2M $67.3M $-344.7M $-179.6M $-169.4M $-147.0M $-140.5M
Operating Margin -274.9% -921.1% 38.5% -419,885.7% -281,078.0%
Interest Expense $5.1M $9.5M $15.6M $24.1M $20.4M $21.5M $21.6M $21.8M
Pretax Income $-86.7M $-117.3M $125.7M $-368.4M $-198.4M $-191.5M $-169.8M $-160.8M
Income Tax Expense $240.0K $51.0K $0 $0 $0 $0 $-408.0K
Net Income $-87.0M $-117.3M $125.7M $-368.4M $-198.4M $-191.5M $-169.4M $-160.8M
Net Margin -312.2% -999.0% 71.9% -483,902.9% -321,608.0%
EPS (Basic) $-0.60 $-1.13 $1.37 $-4.54 $-2.57 $-0.64 $-0.94 $-1.32
EPS (Diluted) $-0.60 $-1.13 $1.36 $-4.54 $-2.57 $-0.64 $-0.94 $-1.32
Shares Outstanding (Basic) 144.1M 104.2M 92.1M 81.2M 77.0M 369.4M 286.0M 131.5M
Shares Outstanding (Diluted) 144.1M 104.2M 92.1M 81.2M 77.0M 369.4M 286.0M 131.5M
Dividends Per Share
← Newer Page 2 of 5 Older →